Advertisement

Topics

sanofi-pasteur Company Profile

14:45 EST 18th November 2017 | BioPortfolio

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


News Articles [660 Associated News Articles listed on BioPortfolio]

UK first EU market for Sanofi Pasteur quadrivalent flu vaccine

Sanofi Pasteur, the vaccines division of French pharma major Sanofi, announced today that, for the first…

Sanofi Pasteur: Creating Vaccines, Protecting Lives

Sanofi Pasteur produce more than 1 billion doses of vaccines yearly to immunize more than 500 million people in the world. During BIO 2015, Roman Chicz, Head of External R&D at Sanofi Pasteur, told Fi...

Influenza And Beyond: Sanofi Pasteur R&D Chief Talks Strategy

Sanofi Pasteur's R&D chief talks to Scrip about the integration process for Protein Sciences, a vaccine company the group acquired...   

Sanofi Pasteur's smallpox vaccine acquired by Emergent for $125M

Sanofi Pasteur's smallpox vaccine ACAM2000 business has been purchased by Emergent BioSolutions for up to $125 million.  -More- 

Sanofi invests in new vaccine production facility in France

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi's position as one of the world's leading seasonal flu vaccin...

Emergent buys Sanofi Pasteur's ACAM2000 smallpox vaccine business for $97.5mm plus earn-outs

Emergent BioSolutions Inc. agreed to pay $97.5mm up front to acquire the ACAM2000 smallpox vaccine business from Sanofi Pasteur.

Sanofi launches first dose of influenza vaccine

Fluzone, Sanofi's influenza vaccine, has been distributed by the company's Sanofi Pasteur unit to US pharmacies, health care  -More- 

Sanofi Completes Protein Sciences Buy

Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal enhances the presence of Sa...

Drugs and Medications [50 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Allegra d 12 hour allergy and congestion [Rebel Distributors Corp]

Allegra-D 12 Hour Allergy and Congestion

Allegra d 12 hour allergy and congestion [Chattem, Inc.]

Allegra-D 12 Hour Allergy and Congestion

Hiprex(methenamine hippurate tablets usp) [sanofi-aventis U.S. LLC]

HIPREX(methenamine hippurate tablets USP)

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) Injection Concentrate, Intraveno...

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.

Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-VAX) licensed in the United States, has announced that their stock of YF-VAX is totally depleted as of July 24, 2017. YF-VAX for c...

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

C-621/15 - W And Others v Sanofi Pasteur: An Example of Judicial Distortion and Indifference to Science.

This case commentary examines the CJEU's recent decision in C-621/15 W and Others v Sanofi Pasteur MSD SNC [2017] ECR I. This commentary critically examines the decision through the lens of the cultur...

Sofosbuvir as treatment against dengue?

Dengvaxia(®) (CTD-TDV), the only licensed tetravalent dengue vaccine by Sanofi Pasteur was made available since 2015. However, administration of CTD-TDV in general has not received the prequalificati...

Current Safety Issues with Quadrivalent Meningococcal Conjugate Vaccines.

Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae. The main prevention strategy for invasive menin...

Clinical Trials [80 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Phase III, open, mono-center study in 177 infants who received a dose of Hep B vaccine at birth or within 1 month after birth. Infants will receive Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T c...

Companies [74 Associated Companies listed on BioPortfolio]

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

sanofi-pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

Sanofi Pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

sanofi pasteur S.A.

It is rare for a company's history to be so tightly interwoven with the history of a major health care discovery. Sanofi pasteur is the result of the meeting of three exceptional destinies, those of m...

March of Dimes and Sanofi Pasteur

More Information about "sanofi-pasteur" on BioPortfolio

We have published hundreds of sanofi-pasteur news stories on BioPortfolio along with dozens of sanofi-pasteur Clinical Trials and PubMed Articles about sanofi-pasteur for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of sanofi-pasteur Companies in our database. You can also find out about relevant sanofi-pasteur Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record